Search Within

Immunology Program Faculty

  1. "Scott Avecilla"
Formats
  1. Meeting Abstract (24)
  2. Journal Article (12)
Groups
  1. Department of Medicine (36)
  2. GSK Faculty (36)
  3. Sloan Kettering Institute Faculty (36)
  4. Bone Marrow Transplant (35)
  5. Center for Hematologic Malignancies (35)
  6. Hematologic Malignancies, Division of (35)

More Groups

People
  1. Scott Avecilla (36)
  2. Sergio Giralt (35)
  3. Miguel-Angel Perales (34)
  4. Richard O'Reilly (33)
  5. Sean Devlin (29)
  6. Hugo Castro-Malaspina (28)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (2)
  4. 2019 (6)
  5. 2018 (6)
  6. 2017 (9)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (18)
  2. Blood (7)
  3. Bone Marrow Transplantation (4)
  4. Blood Advances (2)
  5. Advances in Cell and Gene Therapy (1)
  6. Cytotherapy (1)

More Publications

Publishers
  1. Elsevier Inc. (19)
  2. American Society of Hematology (9)
  3. Nature Publishing Group (5)
  4. Blackwell Publishing (1)
  5. Elsevier Science Ltd. (1)
  6. John Wiley & Sons (1)

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT
    Journal Article

    Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation
    Journal Article

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
    Advances in Cell and Gene Therapy (2021)

    Fulltext@MSK | Save
  • Universal engraftment after allogeneic hematopoietic cell transplantation using cryopreserved CD34-selected grafts
    Journal Article

    Jacob, R. P.; Flynn, J.; Devlin, S. M.; Maloy, M.; Giralt, S. A.; Maslak, P.; O'Reilly, R. J.; Tonon, J. A.; Perales, M. A.; Avecilla, S. T.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin
    Journal Article

    Politikos, I.; Devlin, S. M.; Arcila, M. E.; Barone, J. C.; Maloy, M. A.; Naputo, K. A.; Ruiz, J. D.; Mazis, C. M.; Scaradavou, A.; Avecilla, S. T.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
    Journal Article

    Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Engrafting unit-recipient HLA-allele mismatch is not associated with an increased risk of transplant-related mortality (TRM) or inferior progression-free survival (PFS) after double unit cord blood (CB) transplantation (dCBT) in adults with hematologic malignancies
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Maloy, M. A.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (dCBT) supplemented with haplo-identical CD34+ cells may be associated with enhanced neutrophil recovery but successful myeloid bridging is strongly influenced by haplo CD34+ cell dose and haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M. A.; Naputo, K.; Afuye, A.; Avecilla, S. T.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • A phase II clinical trial of leuprolide for enhancement of immune reconstitution after ex vivo CD34+ cell-selected allogeneic HCT with TBI-based conditioning
    Meeting Abstract

    Cho, C.; Devlin, S. M.; Avecilla, S. T.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Maloy, M.; Maslak, P.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Standard antithymocyte globulin dosing results in poorer outcomes in overexposed patients after ex vivo CD34(+) selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Bhatt, V.; Hilden, P.; Smith, M.; Thoren, K.; Cho, C.; Shah, G. L.; Maloy, M. A.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save